Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing

Autor: CRyPTIC Consortium, 100000 Genomes Project, Allix-Beguec, C, Arandjelovic, I, Bi, L, Beckert, P, Bonnet, M, Bradley, P, Cabibbe, AM, Cancino-Munoz, I, Caulfield, MJ, Chaiprasert, A, Cirillo, DM, Clifton, D, Comas, I, Crook, DW, De Filippo, MR, de Neeling, H, Diel, R, Drobniewski, FA, Faksri, K, Farhat, MR, Fleming, J, Fowler, P, Fowler, TA, Gao, Q, Gardy, J, Gascoyne-Binzi, D, Gibertoni-Cruz, A-L, Gil-Brusola, A, Golubchik, T, Gonzalo, X, Grandjean, L, He, G, Guthrie, JL, Hoosdally, S, Hunt, M, Iqbal, Z, Ismail, N, Johnston, J, Khanzada, FM, Khor, CC, Kohl, TA, Kong, C, Lipworth, S, Liu, Q, Maphalala, G, Martinez, E, Mathys, V, Merker, M, Miotto, P, Mistry, N, Moore, DAJ, Murray, M, Niemann, S, Ong, RT-H, Peto, TEA, Posey, JE, Prammananan, T, Pym, A, Rodrigues, C, Rodrigues, M, Rodwell, T, Rossolini, GM, Padilla, ES, Schito, M, Shen, X, Shendure, J, Sintchenko, V, Sloutsky, A, Smith, EG, Snyder, M, Soetaert, K, Starks, AM, Supply, P, Suriyapol, P, Tahseen, S, Tang, P, Teo, Y-Y, Thuong, TNT, Thwaites, G, Tortoli, E, Omar, SV, van Soolingen, D, Walker, AS, Walker, TM, Wilcox, M, Wilson, DJ, Wyllie, D, Yang, Y, Zhang, H, Zhao, Y, Zhu, B

Publikováno v: NEW ENGLAND JOURNAL OF MEDICINE
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)

Background: The World Health Organization recommends drug-susceptibility testing of Mycobacterium tuberculosis complex for all patients with tuberculosis to guide treatment decisions and improve outcomes. Whether DNA sequencing can be used to accurat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::6ef1d353d9cedec88a579420268d3924
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=2960

Predictive performance of interferon-gamma release assays and the tuberculin skin test for incident tuberculosis: an individual participant data meta-analysis.

Autor: Hamada Y; Institute for Global Health, University College London, London, United Kingdom., Gupta RK; Institute for Global Health, University College London, London, United Kingdom., Quartagno M; MRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, United Kingdom., Izzard A; Institute for Global Health, University College London, London, United Kingdom., Acuna-Villaorduna C; Section of Infectious Diseases, Boston University Medical Center, Boston, MA, USA., Altet N; Unitat de Tuberculosis, Hospital Universitari Vall d'Hebron-Drassanes, Barcelona, Spain.; Unitat de TDO de la Tuberculosis 'Servicios Clínicos', Barcelona, Spain., Diel R; Institute for Epidemiology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany., Dominguez J; Institut d'Investigació Germans Trias i Pujol, CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III, Universitat Autònoma de Barcelona, Barcelona, Spain., Floyd S; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom., Gupta A; Johns Hopkins University School of Medicine, Baltimore, MD, USA., Huerga H; Epicentre, Paris, France., Jones-López EC; Division of Infectious Diseases, Department of Medicine, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA, USA., Kinikar A; Byramjee Jeejeebhoy Government Medical College and Sassoon General Hospital, Pune, Maharashtra, India., Lange C; Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany.; German Center for Infection Research (DZIF), Clinical Tuberculosis Unit, Borstel, Germany.; Respiratory Medicine & International Health, University of Lübeck, Lübeck, Germany.; Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.; Tuberculosis Network European Trials Group (TBnet), Borstel, Germany., van Leth F; Tuberculosis Network European Trials Group (TBnet), Borstel, Germany.; Department of Health Sciences, VU University, Amsterdam, the Netherlands.; Amsterdam Public Health research institute, Amsterdam, the Netherlands., Liu Q; Department of Chronic Communicable Disease, Center for Disease Control and Prevention of Jiangsu Province, Nanjing, Jiangsu Province, PR China., Lu W; Department of Chronic Communicable Disease, Center for Disease Control and Prevention of Jiangsu Province, Nanjing, Jiangsu Province, PR China., Lu P; Department of Chronic Communicable Disease, Center for Disease Control and Prevention of Jiangsu Province, Nanjing, Jiangsu Province, PR China., Rueda IL; Institut d'Investigació Germans Trias i Pujol, CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III, Universitat Autònoma de Barcelona, Barcelona, Spain., Martinez L; Department of Epidemiology, School of Public Health, Boston University, Boston, MA, USA., Mbandi SK; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, and Division of Immunology, Department of Pathology, University of Cape Town, South Africa, Western Cape, South Africa., Muñoz L; Department of Clinical Sciences, University of Barcelona, Barcelona, Spain., Padilla ES; Epicentre, Paris, France., Paradkar M; Byramjee Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune, Maharashtra, India.; Johns Hopkins India, Pune, Maharashtra, India., Scriba T; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, and Division of Immunology, Department of Pathology, University of Cape Town, South Africa, Western Cape, South Africa., Sester M; Tuberculosis Network European Trials Group (TBnet), Borstel, Germany.; Department of Transplant and Infection Immunology, Saarland University, Homburg, Germany., Shanaube K; Zambart, Lusaka, Zambia., Sharma SK; Department of Internal Medicine, All India Institute of Medical Sciences, New Delhi, India.; Department of Molecular Medicine, Jamia Hamdard Institute of Molecular Medicine, Hamdard University, Delhi, India.; Departments of General Medicine & Pulmonary Medicine, JNMC, Datta Meghe Institute of Medical Sciences, Maharashtra, India., Sloot R; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Sotgiu G; Tuberculosis Network European Trials Group (TBnet), Borstel, Germany.; Clinical Epidemiology and Medical Statistics Unit, Department of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, Italy., Thiruvengadam K; National Institute for Research in Tuberculosis, Indian Council of Medical Research, Chennai, Tamil Nadu, India., Vashishtha R; Department of Internal Medicine, All India Institute of Medical Sciences, New Delhi, India., Abubakar I; Institute for Global Health, University College London, London, United Kingdom., Rangaka MX; Institute for Global Health, University College London, London, United Kingdom.; School of Public Health, and Clinical Infectious Disease Research Institute-Africa, University of Cape Town, Cape Town, South Africa.

Publikováno v: EClinicalMedicine [EClinicalMedicine] 2023 Jan 05; Vol. 56, pp. 101815. Date of Electronic Publication: 2023 Jan 05 (Print Publication: 2023).

Evaluating oropharyngeal carcinoma with transcervical ultrasound, CT, and MRI.

Autor: Faraji F; Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, MD, United States., Coquia SF; The Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins Hospital, Baltimore, MD, United States; Division of Medical Imaging Products, Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, United States., Wenderoth MB; The Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins Hospital, Baltimore, MD, United States., Padilla ES; The Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins Hospital, Baltimore, MD, United States., Blitz D; The Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins Hospital, Baltimore, MD, United States., DeJong MR; The Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins Hospital, Baltimore, MD, United States., Aygun N; The Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins Hospital, Baltimore, MD, United States., Hamper UM; The Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins Hospital, Baltimore, MD, United States., Fakhry C; Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, MD, United States. Electronic address: cfakhry@jhmi.edu.

Publikováno v: Oral oncology [Oral Oncol] 2018 Mar; Vol. 78, pp. 177-185. Date of Electronic Publication: 2018 Feb 20.

Human controlled ovarian hyperstimulation outcome is a polygenic trait.

Autor: de Castro F; Unidad de Reproducción Humana Asistida, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Allat Médica, Madrid and Departamento de Genómica Estructural. Neocodex, Sevilla, Spain., Morón FJ, Montoro L, Galán JJ, Hernández DP, Padilla ES, Ramírez-Lorca R, Real LM, Ruiz A

Publikováno v: Pharmacogenetics [Pharmacogenetics] 2004 May; Vol. 14 (5), pp. 285-93.